This conference will bring together stakeholders and policymakers to discuss the way forward following the UK’s Modern Industrial Strategy and what will be needed if its aims are to be achieved to reduce regulatory burdens and speed up innovation. Delegates will also examine the forthcoming Life Sciences Sector Plan, and plans for a streamlined and flexible regulatory framework with accelerated medicine approval processes, support for innovative therapies and increased alignment with international standards.
